These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 10714493)
61. Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives. Kondo H; Sakamoto F; Kawakami K; Tsukamoto G J Med Chem; 1988 Jan; 31(1):221-5. PubMed ID: 3275778 [TBL] [Abstract][Full Text] [Related]
62. Syntheses of 1beta-methylcarbapenems bearing 5-methyl-4-hydroxypyrrolidinone. Pyun DK; Kim BJ; Jung HJ; Kim JH; Lee JS; Lee WK; Lee CH Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):415-8. PubMed ID: 11911211 [TBL] [Abstract][Full Text] [Related]
63. Synthesis and antibacterial activity of 1beta-methyl-2-(5-substituted thiazolidinopyrrolidin-3-ylthio)carbapenems and related compounds. Oh CH; Cho HW; Lee IK; Gong JY; Choi JH; Cho JH Arch Pharm (Weinheim); 2002 Apr; 335(4):152-8. PubMed ID: 12112035 [TBL] [Abstract][Full Text] [Related]
64. Design, synthesis and antibacterial activities of a series of new 2-oxaisocephems. Wu J; Wu X; Lei F; Yuan H; Hai L; Wu Y Bioorg Med Chem Lett; 2012 Aug; 22(16):5293-6. PubMed ID: 22795329 [TBL] [Abstract][Full Text] [Related]
66. Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084. Isoda T; Ushirogochi H; Satoh K; Takasaki T; Yamamura I; Sato C; Mihira A; Abe T; Tamai S; Yamamoto S; Kumagai T; Nagao Y J Antibiot (Tokyo); 2006 Apr; 59(4):241-7. PubMed ID: 16830892 [TBL] [Abstract][Full Text] [Related]
67. Doripenem: S 4661. Drugs R D; 2003; 4(6):363-5. PubMed ID: 14584966 [TBL] [Abstract][Full Text] [Related]
68. Arginine-pyrimidine conjugates with therapeutic and prophylactic activity in lethal bacterial infections. Haebich D; Kroll HP; Lerchen HG Bioorg Med Chem Lett; 2009 Nov; 19(22):6317-8. PubMed ID: 19819137 [TBL] [Abstract][Full Text] [Related]
69. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria. Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581 [TBL] [Abstract][Full Text] [Related]
70. In vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections. Miyazaki S; Hosoyama T; Furuya N; Ishii Y; Matsumoto T; Ohno A; Tateda K; Yamaguchi K Antimicrob Agents Chemother; 2001 Jan; 45(1):203-7. PubMed ID: 11120966 [TBL] [Abstract][Full Text] [Related]
71. Studies on the synthesis and structure-activity relationships of 2-(2-functionalized pyrrolidin-4-ylthio)-1 beta-methylcarbapenems. Lee HW; Kim EN; Son HJ; Ahn SK; Chung KH; Kim JW; Lee CR Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2326-30. PubMed ID: 8996864 [TBL] [Abstract][Full Text] [Related]
72. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in-vitro biological activity - part II. Kim SJ; Cho JH; Oh CH Arch Pharm (Weinheim); 2009 Sep; 342(9):528-32. PubMed ID: 19598286 [TBL] [Abstract][Full Text] [Related]
73. Synthesis and antibacterial activity of aromatic and heteroaromatic amino alcohols. de Almeida CG; Reis SG; de Almeida AM; Diniz CG; da Silva VL; Le Hyaric M Chem Biol Drug Des; 2011 Nov; 78(5):876-80. PubMed ID: 21883957 [TBL] [Abstract][Full Text] [Related]
74. Synthesis and biological activity of novel antibacterial quinazolines. Bedi PM; Kumar V; Mahajan MP Bioorg Med Chem Lett; 2004 Oct; 14(20):5211-3. PubMed ID: 15380229 [TBL] [Abstract][Full Text] [Related]
75. An update on the synthesis and antibacterial effects of carbapenems. Galal AM; Gul W; Noreddin AM; Slade D Recent Pat Antiinfect Drug Discov; 2010 Jan; 5(1):23-43. PubMed ID: 19929840 [TBL] [Abstract][Full Text] [Related]
77. In vitro and in vivo antibacterial activity of Pogostone. Peng F; Wan F; Xiong L; Peng C; Dai M; Chen J Chin Med J (Engl); 2014; 127(23):4001-5. PubMed ID: 25430439 [TBL] [Abstract][Full Text] [Related]
78. A review of the carbapenems in clinical use and clinical trials. Lo TS; Welch JM; Alonto AM; Vicaldo-Alonto EA Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):123-31. PubMed ID: 18673125 [TBL] [Abstract][Full Text] [Related]
79. Pharmacokinetic determinants of carbapenem therapy in neonates and children. Blumer JL Pediatr Infect Dis J; 1996 Aug; 15(8):733-7. PubMed ID: 8858691 [No Abstract] [Full Text] [Related]
80. Synthesis and properties of 2-(naphthosultamyl)methyl-carbapenems with potent anti-MRSA activity: discovery of L-786,392. Ratcliffe RW; Wilkening RR; Wildonger KJ; Waddell ST; Santorelli GM; Parker DL; Morgan JD; Blizzard TA; Hammond ML; Heck JV; Huber J; Kohler J; Dorso KL; St Rose E; Sundelof JG; May WJ; Hammond GG Bioorg Med Chem Lett; 1999 Mar; 9(5):679-84. PubMed ID: 10201828 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]